Back to CRVS
GOLDMAN SACHS GROUP INC → CRVS
GOLDMAN SACHS GROUP INC CRVS Position History
Corvus Pharmaceuticals, Inc. • Healthcare
Quarters held
12
Latest value
$3.7M
Q2 2026
Peak value
$19.8M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $603K |
| Q2 2025 | $78K |
| Q3 2025 | $2.7M |
| Q3 2025 | $540K |
| Q4 2025 | $2.2M |
| Q4 2025 | $2M |
| Q4 2025 | $2M |
| Q4 2025 | $2.2M |
| Q1 2026 | $19.7M |
| Q1 2026 | $2.9M |
| Q2 2026 | $19.8M |
| Q2 2026 | $3.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $3.7M | 249.4K | — | — |
| Q2 2026 | $19.8M | 1.33M | — | — |
| Q1 2026 | $2.9M | 195.5K | — | — |
| Q1 2026 | $19.7M | 1.35M | — | — |
| Q4 2025 | $2.2M | 291.9K | — | — |
| Q4 2025 | $2M | 261.5K | — | — |
| Q4 2025 | $2M | 261.5K | — | — |
| Q4 2025 | $2.2M | 291.9K | — | — |
| Q3 2025 | $540K | 73.3K | — | — |
| Q3 2025 | $2.7M | 372.4K | — | — |
| Q2 2025 | $78K | 19.4K | — | — |
| Q2 2025 | $603K | 150.8K | — | — |